ASCO takes long look at clinically meaningful outcomes for patients
- An important initiative discussed at this year's American Society of Clinical Oncologists conference in Chicago is to increase the focus on clinically meaningful outcomes as a way to make treament decisions.
- Most of the new cancer drugs approved in the last several years only extend life by several months, compared with standard therapy..
- Most of the new treatments in question cost between $5,000 and $7,000 a month..
According to Lowell Schwipper, MD, one way to achieve more CMOs is to focus on personalized care. That means determining when a patient can benefit from targeted therapy based on genomic parameters. Look for an increased focus on "smart clinical trials" that include patients with diseases that express specific validated targets.